Longeveron (LGVN) Earnings Date & Reports

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LGVN is expected to report earnings to fall 78.92% to -21 cents per share on May 10

Q1'24

Est.

$-0.22

Q4'23

Missed

by $0.81

Q3'23

Missed

by $0.05

Q2'23

Missed

by $0.02

Q1'23

Est.

$-0.22

The last earnings report on February 27 showed earnings per share of -101 cents, missing the estimate of -20 cents. With 114.00K shares outstanding, the current market capitalization sits at 22.54M.

View a ticker or compare two or three

Compare

LGVN